Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04425083
Other study ID # TSGH-C105-025
Secondary ID
Status Completed
Phase
First received
Last updated
Start date November 18, 2015
Est. completion date December 31, 2017

Study information

Verified date June 2020
Source Tri-Service General Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study is a cross-sectional study. The purpose is to understand the characteristics of Chinese medicine constitutional syndrome in patients with polycystic ovary. In addition, the health-related quality of life (SF-36), mental state (stress, depression) of patients with polycystic ovary , Anxiety) and the relationship between hormone biochemical indicators and TCM constitutional syndromes, to develop a pioneering study on TCM constitution diagnosis and life guidelines for polycystic ovarian patients and future clinical adjuvant therapy.


Description:

The study conducted in the Obstetrics and Gynecology Department of the Neihu District of the Taipei Three Military General Hospital. It is expected that 200 cases of polycystic ovary will be diagnosed by specialists; "Quality of Life Questionnaire (SF-36)" evaluates the quality of life of patients; "BAI and BDI-II" evaluates patients 'anxiety and depression; "Stress Perception Scale" evaluates patients' life stress And testing the blood indexes of patients such as FSH, LH, E2, testosterone, TSH, prolactine. Observe the correlation between the quality of life, psychological state, and blood test values of polycystic ovarian patients with physical characteristics of traditional Chinese medicine.


Recruitment information / eligibility

Status Completed
Enrollment 180
Est. completion date December 31, 2017
Est. primary completion date December 31, 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 20 Years and older
Eligibility Inclusion Criteria:

A polycystic ovarian patient was diagnosed by a specialist in obstetrics and gynecology according to the diagnostic criteria set by the Rotterdam ESHRE / ASRM-sponsored PCOS workshop group (2004) in 2003.

Exclusion Criteria:

1. Exclude diseases similar to the clinical manifestations of polycystic ovary, such as cushing syndrome, congenital adrenal hyperplasia, thyroid dysfunction, and hyperprolactinemia.

2. Diagnose a clear mental disorder (such as schizophrenia, severe depression) or take psychiatric drugs (anti-depression or anxiety drugs).

3. Pregnancy, oral contraceptives, use high-dose exogenous androgens, breastfeeding.

4. Those with a history of stroke, myocardial infarction, major trauma or surgery within the past six months.

5. Have taken Chinese medicine in the past month.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
no intervention
no intervention

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Tri-Service General Hospital

Outcome

Type Measure Description Time frame Safety issue
Primary participants with PCOS and non-PCOS assessed Chinese Body Constitution & Syndromes by Body Constitution Questionnaire The TCM Body Constitution Questionnaire (BCQ) was developed by Su and is a tool used to measure and study constitution deviations clinically. The questionnaire comprises 44 questions and employs a Likert 5-point scale (from 1, "Never happens," to 5, "Always happens"). The instrument consists of three subscales. The yang-xu and yin-xu constitution subscales each have 19 questions, and the stasis constitution subscale has 16 questions. The three measures share some questions. The higher the score is, the more significant the constitution deviation is. When the yang-xu constitution score is = 30.5, the respondent is diagnosed as yang-xu. When the yin-xu constitution score is = 29.5, the respondent is diagnosed as yin-xu. For the phlegm stasis constitution, the standard is = 26.5 points. The instrument has favorable factorial validity. Cronbach's a of each subscale is 0.85-0.88, and Cronbach's aof the overall BCQ reaches 0.90. No subsequent intervention, data collected and analyzed at the time of enrolled (cross-sectional study)
Secondary work schedule (Day shift, Evening shift, Night shift, Not fixed, or Unemployed) of participants with PCOS and non-PCOS were collected Participant reply her work schedule (Day shift, Evening shift, Night shift, Not fixed, or Unemployed) No subsequent intervention, data collected and analyzed at the time of enrolled (cross-sectional study)
Secondary average sleep duration of participants with PCOS and non-PCOS were collected Participant reply her average sleep duration (hours) No subsequent intervention, data collected and analyzed at the time of enrolled (cross-sectional study)
Secondary habit of staying up late of participants with PCOS and non-PCOS were collected Participant reply her frequency(No, Sometimes, Often) of staying up late (sleeping after midnight) No subsequent intervention, data collected and analyzed at the time of enrolled (cross-sectional study)
Secondary habit of smoking of participants with PCOS and non-PCOS were collected Participant reply her frequency of smoking (No, Sometimes, Less than a pack a day) No subsequent intervention, data collected and analyzed at the time of enrolled (cross-sectional study)
Secondary habit of drinking of participants with PCOS and non-PCOS were collected Participant reply her frequency of drinking (No, Sometimes, often) No subsequent intervention, data collected and analyzed at the time of enrolled (cross-sectional study)
Secondary habit of exercise of participants with PCOS and non-PCOS were collected Participant reply her frequency of exercise (No, Sometimes, often) No subsequent intervention, data collected and analyzed at the time of enrolled (cross-sectional study)
Secondary dietary habit (Nonvegetarian or vegetarian) of participants with PCOS and non-PCOS were collected Participant reply her dietary habit (Nonvegetarian or vegetarian) No subsequent intervention, data collected and analyzed at the time of enrolled (cross-sectional study)
Secondary dietary flavor preference (sour, bitter,sweet, spicy, salty) of participants with PCOS and non-PCOS were collected Participant reply yes or no about her dietary flavor preference (sour, bitter,sweet, spicy, salty) No subsequent intervention, data collected and analyzed at the time of enrolled (cross-sectional study)
Secondary Anxiety of participants with PCOS and non-PCOS as assessed by Beck Anxiety Inventory The Beck Anxiety Inventory (BAI) was established by Aaron T. Beck and his research team to measure the anxiety levels of adults and teenagers. It is a self-completed questionnaire with 21 items. The questions ask respondents whether they have experienced some common symptoms of anxiety in the previous week, including numbness or tingling, feeling hot, being unable to relax, and fear of the worst happening. The respondents report on a 4-point Likert scale that ranges from 0 (Not at all) to 3 (Severely - it bothered me a lot). The higher the total score is, the more severe the anxiety symptoms are. A total score of 0-7 implies the mildest anxiety, 8-15 is mild anxiety, 16-25 represents moderate anxiety, and 26-63 is severe anxiety. In the present study, the Chinese version of the BAI had a Cronbach's a of 0.95 and a split-half reliability of 0.92. The total scores were multiplied by 1.19, and the resulted integers were taken as the standard scores. No subsequent intervention, data collected and analyzed at the time of enrolled (cross-sectional study)
Secondary Depression of participants with PCOS and non-PCOS as assessed by Beck Depression Inventory-second edition (BDI-II) The Beck Depression Inventory-second edition (BDI-II) was developed by Beck . It measures the depression levels of teenagers and adults through 21 questions. It consists of questions representative of the symptoms and attitudes of depression, such as feeling sad, losing interest, decreased appetite, and feeling tired. For each item, respondents select the option that best describes how they felt over the previous 2 weeks. Every question has anchors arranged according to severity, and the score ranges from 0 to 3 points. The higher the total score is, the more severe the depression symptoms are. A total score of 0-13 points is in the normal range, 14-19 implies mild depression, 20-28 moderate depression, and 29-63 severe depression. No subsequent intervention, data collected and analyzed at the time of enrolled (cross-sectional study)
See also
  Status Clinical Trial Phase
Completed NCT03142633 - MicroRNA as Biomarkers for Development of Metabolic Syndrome in Women With Polycystic Ovary Syndrome
Completed NCT06158932 - A Single Group Study to Evaluate the Effects of a Myo-Inositol and D-Chiro Inositol Supplement on Symptoms Associated With Polycystic Ovary Syndrome and Hormone Imbalance N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Active, not recruiting NCT02500147 - Metformin for Ectopic Fat Deposition and Metabolic Markers in Polycystic Ovary Syndrome (PCOS) Phase 4
Completed NCT04932070 - Berberine and Polycystic Ovary Syndrome N/A
Suspended NCT03652987 - Endocrine and Menstrual Disturbances in Women With Polycystic Ovary Syndrome (PCOS)
Completed NCT03480022 - Liraglutide 3mg (Saxenda) on Weight, Body Composition, Hormonal and Metabolic Parameters in Obese Women With PCOS Phase 3
Active, not recruiting NCT03043924 - Functional Study of the Hypothalamus in Magnetic Resonance Imaging (MRI) in Polycystic Ovary Syndrome (PCOS) N/A
Completed NCT05246306 - Aerobic Capacity and Physical Fitness Level of Adolescents With PCOS
Completed NCT05981742 - Effects of Combined Metformin and Cabergoline in Comparison With Metformin Only Therapy on Ovarian and Hormonal Activities in Iraqi Patients With PCOS Phase 2
Completed NCT05702957 - Letrozole vs Clomiphene Citrate for Induction of Ovulation in Women With Polycystic Ovarian Syndrome Phase 2/Phase 3
Completed NCT05029492 - Effect of Visceral Manipulation on PCOS N/A
Not yet recruiting NCT02255578 - Endobarrier Treatment in Women With PCOS Phase 3
Completed NCT02924025 - Motivational Interviewing as an Intervention for PCOS N/A
Not yet recruiting NCT00883259 - Metformin and Gestational Diabetes in High-risk Patients: a RCTs Phase 4
Completed NCT02098668 - Mathematical Model for the Human Menstrual Cycle, Endocrinological Diseases and Fertility Treatment-PAEON N/A
Withdrawn NCT01638988 - Clomifene Citrate Versus Metformin in First-line Treatment of Infertility in Patients With Polycystic Ovary Syndrome and a Resistance to Insulin Phase 3
Completed NCT01462864 - Development of a Structured Education Programme for Women With Polycystic Ovary Syndrome N/A
Recruiting NCT01431352 - Letrozole Versus Chinese Herbal Medicine on Polycystic Ovary Syndrome (PCOS) N/A
Completed NCT00989781 - Mechanisms of Increased Androgen Production Among Women With Polycystic Ovary Syndrome N/A